- Home
- / Pelican Expression Technology
Pelican Expression Technology
Revenue
$50.3 M
FY, 2019
Pelican Expression Technology Summary
Company Summary
- Overview
- Pelican Expression Technology is a platform of Ligand Pharmaceuticals for recombinant protein production. It is used for the production of enzymes, peptides, antibody derivatives, and engineered non-natural proteins.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2009
- HQ
- San Diego, CA, US | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
San Diego, CA HQ
United States
10790 Roselle Street
Pelican Expression Technology Financials
Summary Financials
- Revenue (Q2, 2020)
- $781.0K
- Gross profit (Q2, 2020)
- $101.0K
- Net income (Q2, 2020)
- ($10.3M)
- Cash (Q2, 2020)
- $61.0M
- EBIT (Q2, 2020)
- ($10.3M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026